Recommendations of a Task Force of the European Society of Cardiology and the European Resuscitation Council on The Pre-hospital Management of Acute Heart Attacks

Resuscitation

Volumn 38, Issue 2, 1998, Pages 73-98

  Author, A ^a  

^a NONE

Author keywords

Acute coronary syndromes; Acute myocardial infarction; Chain of survival; Defibrillation; Drug therapy; Emergency medical systems; Reperfusion therapy; Sudden cardiac death

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; MORPHINE; NITRATE;

ACUTE HEART INFARCTION; AMBULANCE; BLOOD CLOT LYSIS; CARDIOLOGY; CORONARY ARTERY DISEASE; DEFIBRILLATION; EMERGENCY; EUROPE; FIBRINOLYTIC THERAPY; FIRST AID; HEALTH CARE ORGANIZATION; HEART MUSCLE REPERFUSION; HUMAN; MORTALITY; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SUDDEN DEATH; SURVIVAL;

EID: 0345698965     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(98)00064-1     Document Type: Note

References (148)

1. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Acute myocardial infarction: pre-hospital and in-hospital management. Eur Heart J 1996; 17:43-63.
2. Chambless L, Keil U, Dobson A, Mähönen M, Kuulasmaa K, Rajakangas A-M, Löwel H, Tunstall-Pedoe H. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Circulation. 96:1997;3849-3859.
3. Sans S, Kesteloot H, Kromhout D The burden of cardiovascular mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J. 18:1997;1231-1248.
4. Norris RM Fatality outside hospital from acute coronary events in three British health districts: 1994-1995. Br Med J. 316:1998;1065-1070.
5. Löwel H, Lewis M, Hörmann A Prognostic significance of the pre-hospital phase in acute myocardial infaction: results of the Augsburg infarct register, 1985-1988 (in German). Dtsch Med Wschr. 116:1991;729-733.
6. Dellborg M, Eriksson P, Riha M, Swedberg K Declining hospital mortality in acute myocardial infarction. Eur Heart J. 15:1994;5-9.
7. Koenig W, Löwel H, Lewis M, Hörmann A Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg myocardial infarction follow-up study 1985-1993. Eur Heart J. 17:1996;1199-1206.
8. Löwel H, Lewis M, Keil U, Hörmann A, Bolte H-D, Willich S, Gostomzyk J Time trends of acute myocardial infarction morbidity, mortality, 28 day-case-fatality and acute medical care: results of the Augsburg myocardial infarction register from 1985 to 1992 (in German). Zeitschrift für Kardiol. 84:1995;596-605.
9. Tunstall-Pedoe H, Morrison C, Woodward M, Fitzpatrick B, Watt G Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985-1991. Presentation, diagnosis, treatment, and 28 day case fatality of 3991 events in men and 1551 events in women. Circulation. 93:1996;1981-1992.
10. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monson CE, Leavy J, Weiss M, Borrico S, Gorlin R, Fuster V Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 12:1988;56-62.
11. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs. duration of coronary occlusion in dogs. Circulation. 56:1977;786-794.
12. Weaver WD. Time to thrombolytic treatment: factors affecting delay and their influence on outcome. J Am Coll Cardiol 1995;25 suppl:3S-9S.
13. Boersma E, Maas ACP, Deckers JW, Simoons ML Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 348:1996;771-775.
14. Charney R, Cohen M The role of the coronary circulation in limiting myocardial ischemia and infarct size. Am Heart J. 126:1993;937-945.
15. Rentrop KP Thrombolytic therapy in patients with acute myocardial infarction. Circulation. 71:1985;627-631.
16. Rogers WJ, Hood WP, Mantle JA, Baxley WA, Kirklin JK, Zorn GL, Nath HP Return of left ventricular function after reperfusion in patients with myocardial infarction: importance of subtotal stenoses or intact collaterals. Circulation. 69:1984;338-349.
17. Anzai T, Yoshikawa T, Asakura Y, Abe S, Akaishi M, Mitamura H, Handa S, Ogawa S Preinfarction angina as a major predictor of left ventricular function an long-term prognosis after a first Q wave myocardial infarction. J Am Coll Cardiol. 26:1995;319-327.
18. Lesnefsky EJ, Lundergan CF, Hodgson JMcB, Nair R, Reiner JS, Greenhouse SW, Califf RM, Ross AM Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience. J Am Coll Cardiol. 28:1996;331-337.
19. Haider AW, Andreotti F, Hackett DR, Tousoulis D, Kluft C, Maseri A, Davies GJ Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damage. J Am Coll Cardiol. 26:1995;662-667.
20. Kannel WB, Thomas HE Sudden coronary death: the Framingham study. Ann NY Acad Sci. 382:1982;3-21.
21. Wennerblom B, Holmberg S Death outside hospital with special reference to heart disease. Eur Heart J. 5:1984;266-274.
22. O'Doherty M, Taylor DI, Quinn E, Vincent R, Chamberlain DA Five hundred patients with myocardial infarction monitored within 1 h of symptoms. Br Med J. 286:1983;1405-1408.
23. Campbell RWF, Murray A, Julian DG Ventricular arrhythmias in first 12 h of acute myocardial infarction. Natural history study. Br Heart J. 46:1981;351-357.
24. Viskin S, Belahassen B Idiopathic ventricular fibrillation. Am Heart J. 120:1990;661-671.
25. Schaffer WA, Cobb LA Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation. New Engl J Med. 293:1975;259-262.
26. Blohm MB, Hartford M, Karlson BW, Luepker RV, Herlitz J An evaluation of the results of media and educational campaigns designed to shorten the time taken by patients with acute myocardial infarction to decide to go to hospital. Heart. 76:1996;430-434.
27. Meischke H, Ho MT, Eisenberg MS, Schaeffer SM, Larsen MP Reasons patients with chest pain delay or do not call 911. Ann Emerg Med. 25:1995;193-197.
28. Hackett TP, Cassem NH Factors contributing to delay in responding to the signs and symptoms of acute myocardial infarction. Am J Cardiol. 24:1969;651-658.
29. Gilchrist IC Patient delay before treatment of myocardial infarction. Br Med J. 1:1973;535-537.
30. Rawles JM, Metcalfe MJ, Shirreffs C, Jennings K, Kenmure ACF Association of patient delay with symptoms, cardiac enzymes, and outcome in acute myocardial infarction. Eur Heart J. 11:1990;643-648.
31. Kenyon LW, Ketterer MW, Gheorghiade M, Goldstein S Psychological factors related to prehospital delay during acute myocardial infarction. Circulation. 84:1991;1969-1976.
32. Trent RJ, Rose EL, Adams JN, Jennings KP, Rawles JM Delay between the onset of symptoms of acute myocardial infarction and seeking medical assistance is influenced by left ventricular function at presentation. Br Heart J. 73:1995;125-128.
33. Rawles J, Sinclair C, Waugh N. Call-to-needle times in Grampian: the pivotal role of the general practitioner in achieving early thrombolysis (abstract). Heart 1996;75 suppl 1:63.
34. Birkhead JS Time delays in provision of thrombolytic treatment in six district hospitals. Br Med J. 305:1992;445-448.
35. Bleeker JK, Simoons ML, Erdman RAM, Leenders CM, Kruyssen HACM, Lamers LM, van der Does E Patient and doctor delay in acute myocardial infarction: a study in Rotterdam, the Netherlands. Br J Gen Pract. 45:1995;181-184.
36. Leprohon J, Patel VL Decision-making strategies for telephone triage in emergency medical services. Med Decis Mak. 15:1995;240-253.
37. Sramek M, Post W, Koster RW Telephone triage of cardiac emergency calls by dispatchers. A prospective study of 1386 emergency calls. Br Heart J. 71:1994;440-445.
38. Culley LL, Henwood DK, Clark JJ, Eisenberg MS, Horton C Increasing the efficiency of emergency medical services by using criteria based dispatch. Ann Emerg Med. 24:1994;867-872.
39. Ahnefeld FW Die Wiederbelebung bei Kreislaufstillstand. Verhandlungen eutsche Gesellschaft für Innere Medizin. 74:1968;279-287.
40. Cummins R, Ornato JP, Thies WH, Pepe PE Improving survival from sudden cardiac arrest: the 'chain of survival' concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care Committee American Heart Association. Circulation. 83:1991;1832-1847.
41. The Council of the European Communities: Council decision of 29/7/91 on the introduction of a single European emergency call number (91/396/EEC). OJ 1991;L217:6.08.1991.
42. Herlitz J, Ekstrom L, Wennerblom B, Axelsson Å, Bång A, Holmberg S Effect of bystander initiated cardiopulmonary resuscitation on ventricular fibrillation and survival after witnessed cardiac arrest outside hospital. Br Heart J. 72:1994;408-412.
43. Bossaert L, Van Hoeyweghen R. Cerebral Resuscitation Study Group. Bystander cardiopulmonary resuscitation (CPR) in out-of-hospital cardiac arrest. Resuscitation 1989;17 suppl:S55-S69.
44. Stults KR, Brown DD, Schug VL, Bean JA Prehospital defibrillation performed by emergency medical technicians in rural communities. New Engl J Med. 310:1984;219-223.
45. European Resuscitation Council guidelines for the use of automated external defibrillators by EMS providers and first responders. A statement from the Early Defibrillation Task Force, with contributions from the Working Groups on Basic and Advanced Life Support, and approved by the Executive Committee of the European Resuscitation Council. Resuscitation 1998;37:91-4.
46. Weaver WD, Hill D, Fahrenbruch CE, Copass MK, Martin JS, Cobb LA, Hallstrom AP Use of the automatic external defibrillator in the management of out-of-hospital cardiac arrest. New Engl J Med. 319:1988;661-666.
47. White RD, Asplin BR, Bugliosi TF, Hankins DG High discharge survival rate after out-of-hospital ventricular fibrillation with rapid defibrillation by police and paramedics. Ann Emerg Med. 28:1996;480-485.
48. O'Rourke MF, Donaldson E, Geddes JS An airline cardiac arrest program. Circulation. 96:1997;2849-2853.
49. Bossaert L, Callanan V, Cummins RO Early defibrillation. An advisory statement by the Advanced Life Support Working Group of the International Liaison Committee on Resuscitation. Resuscitation. 34:1997;113-115.
50. Jaggarao NSV, Heber M, Grainger R, Vincent R, Chamberlain DA Use of an automated external defibrillator by ambulance staff. Lancet. 2:1982;73-75.
51. Eisenberg MS, Horwood BT, Cummins RO, Reynolds-Haertle R, Hearne TR Cardiac arrest and resuscitation: a tale of 29 cities. Ann Emerg Med. 19:1990;179-186.
52. Het Belgisch Staatsblad, 1 January 1961; Article 422 bis-ter.
53. Capone RJ, Visco J, Curwen E, VanEvery S The effect of early prehospital transtelephonic coronary intervention on morbidity and mortality: experience with 284 post myocardial infarction patients in a pilot program. Am Heart J. 107:1984;1153-1160.
54. Culley LL, Clark JJ, Eisenberg MS, Larsen MP Dispatcher-assisted telephone CPR: common delays and time standards for delivery. Ann Emerg Med. 20:1991;362-366.
55. Eisenberg MS, Hallstrom AP, Carter WB, Cummins RO, Bergner L, Pierce J Emergency CPR instructions via the telephone. Am J Public Health. 75:1985;47-50.
56. GREAT Group. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. Br Med J 1992;305:548-553.
57. The European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. New Engl J Med 1993;329:383-389.
58. Grijseels EWM, Deckers JW, Hoes AW, Boersma E, Hartman JAM, van der Does E, Simoons ML Implementation of a pre-hospital decision rule in general practice. Triage of patients with suspected myocardial infarction. Eur Heart J. 17:1996;89-95.
59. Karagounis L, Ipsen SK, Jessop MR, Gilmore KM, Valenti DA, Clawson JJ, Teichman S, Anderson JL Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction. Am J Cardiol. 66:1990;786-791.
60. Assanelli D, Zywietz C, Mertins V, Canclini S, Giovanni G, Vignali S. Digital ECG transmission from ambulance cars with application of the European standard communications protocol Scp-Ecg. Eur Heart J 1996;17 suppl:579.
61. Jollis JG, DeLong ER, Peterson ED, Muhlbaier LH, Fortin DF, Califf RM, Mark DB Outcome of acute myocardial infarction according to the specialty of the admitting physician. New Engl J Med. 335:1996;1880-1887.
62. National heart attack alert program coordinating committee 60 min to treatment working group. Emergency department: rapid identification and treatment of patients with acute myocardial infarction. US Department of Health and Human Services, National Institutes of Health, 1993.
63. Burns JMA, Hogg KJ, Rae AP, Hillis WS, Dann FG Impact of a policy of direct admission to a coronary care unit on use of thrombolysis treatment. Br Heart J. 61:1989;322-325.
64. Rosenthal E, Thomas N, Quinn E, Chamberlain D, Vincent R Transcutaneous pacing for cardiac emergencies. Pace. 11:1988;2160-2167.
65. Tachakra SS, Pawsey S, Beckett M, Potts D, Idowu A Outcome of patients with chest pain discharged from an accident and emergency department. Br Med J. 302:1991;504-505.
66. Pell ACH, Miller HC Delays in admission of patients with myocardial infarction to coronary care: implications for thrombolysis. Health Bull. 48:1990;225-233.
67. Emerson PA, Russell NJ, Wyatt J, Crichton N, Pantin CF, Morgan AD, Fleming PR An audit of doctor's management of patients with chest pain in the accident and emergency department. Q J Med. 263:1989;213-220.
68. Pell ACH, Miller HC, Robertson CE, Fox KAA Effect of 'fast track' admission for acute myocardial infarction on delay to thrombolysis. Br Med J. 304:1992;83-87.
69. More R, Moore K, Quinn E, Perez Avila C, Davidson C, Vincent R, Chamberlain, D. Delay times in the administration of thrombolytic therapy: the Brighton experience. Int J Cardiol 1995;49 suppl:S39-S46.
70. Goldman L, Cook EF, Brand DA, Lee TH, Rouan GW, Weisberg MC, Acampora D, Stasiulewicz C, Walshon J, Terranova G, Gottlieb L, Kobernick M, Goldstein-Wayne B, Copen D, Daley K, Brandt AA, Jones D, Mellors J, Jakubowski R A computer protocol to predict myocardial infarction in emergency department patients with chest pain. New Eng J Med. 318:1988;797-803.
71. Pozen MW, d'Agostino RB, Mitchell JB, Rosenfeld DM, Guglielmino JT, Schwartz ML, Teebagy N, Valentine JM, Hood WB The usefulness of a predictive instrument to reduce inappropriate admissions to the coronary care unit. Ann Intern Med. 92:1980;238-242.
72. Tierney WM, Roth BJ, Psaty B, McHenry R, Fitzgerald J, Stump DL, Anderson FK, Ryder KW, McDonald CJ, Smith DM Predictors of myocardial infarction in emergency room patients. Crit Care Med. 13:1985;526-531.
73. Adams J, Trent R, Rawles J Earliest electrocardiographic evidence of myocardial infarction: implications for thombolytic treatment. Br Med J. 307:1993;409-413.
74. Srikanthan VS, Pell AC, Prasad N, Tait GW, Rae AP, Hogg KJ, Dunn FG Use of fax facility improves decision making regarding thrombolysis in acute myocardial infarction. Heart. 78:1997;198-200.
75. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994;308:81-116.
76. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;ii:349-60.
77. Reilly IA, Fitzgerald GA Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs. Blood. 69:1987;180-186.
78. Collins R, MacMahon S, Flather M, Baigent C, Remvig L, Mortensen S, Appleby P, Godwin J, Yusuf S, Peto R Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials. Br Med J. 313:1996;652-659.
79. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction. Lancet 1992;339:753-770.
80. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction. Lancet 1990;336:65-71.
81. ISIS-I (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-I. Lancet 1986;2:57-66.
82. The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. Eur Heart J 1985;6:199-226.
83. Borzak S, Gheorghiade M Early intravenous β-blocker combined with thrombolytic therapy for acute myocardial infarction: the thrombolysis in myocardial infarction (TIMI-2) trial. Prog Cardiovasc Dis. 36:1993;261-266.
84. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. B-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 27:1985;335-371.
85. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. New Engl J Med 1989;320:618-627.
86. Leizorovicz A, Teppe J-P, Payen C, Haugh MC, Boissel J-P Pre-hospital treatment of patients with suspected acute myocardial using a β-blocking agent: a double-blind feasibility study. Clin Trials Meta-Analys. 29:1994;125-138.
87. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6 week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-1122.
88. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685.
89. Ferguson JJ, Diver DJ, Boldt M, Pasternak RC Significance of nitroglycerin-induced hypotension with inferior wall acute myocardial infarction. Am J Cardiol. 64:1989;311-314.
90. Rutherford JD, Pfeffer MA, Moyé LE, Davis BR, Flaker GC, Kowey PR, Lamas GA, Miller HS, Packer M, Rouleau JL, Braunwald E Effects of captopril on ischemic events after myocardial infarction: results of the survival and ventricular enlargement trial. Circulation. 90:1994;1731-1738.
91. Pfeffer MA, Greaves SC, Arnold MO, Glynn RJ, LaMotte FS, Lee RT, Menapace FJ, Rapaport ER, Ridker PM, Rouleau J-L, Solomon SD, Hennekens CH Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. Circulation. 95:1997;2643-2651.
92. MacMahon S., Collins R, Peto R, Koster RW, Yusuf S Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized, controlled trials. J Am Med Assoc. 260:1988;1910-1916.
93. Hine LK, Laird N, Hewitt P, Chalmers TC Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med. 149:1989;2694-2698.
94. Teo KK, Yusuf S, Furberg SD Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. J Am Med Assoc. 270:1993;1589-1595.
95. Fibrinolytic Therapy Trialists' Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-322.
96. Rawles J What is the likely benefit of earlier thrombolysis? Eur Heart J. 17:1996;991-995.
97. Weaver WD, Cerqueira M, Hallström AP, Litwin PE, Martin JS, Kudenchuk PJ, Eisenberg M Pre-hospital-initiated vs. hospital-initiated thrombolytic therapy. J Am Med Assoc. 270:1993;1211-1216.
98. Rawles J Quantification of the benefit of earlier thrombolytic therapy: 5 year results of the Grampian early anistreplase trial (GREAT). J Am Coll Cardiol. 30:1997;1181-1186.
99. Brouwer MA, Martin JS, Maynard JS, Wirkus M, Litwin PE, Verheugt FWA, Weaver WD Influence of early pre-hospital thrombolysis on mortality and event-free survival (The Myocardial Infarction Triage and Intervention [MITI] randomized trial). Am J Cardiol. 78:1996;497-502.
100. Cannon CP, Antman EM, Walls R, Braunwald E Time as an adjunctive agent to thrombolytic therapy. J Thrombosis Thrombolysis. 1:1994;27-34.
101. Stone GW, Grines CL, Rothbaum D, Browne KF, O'Keefe J, Overlie PA, Donohue BC, Chelliah N, Vlietstra R, Catlin T, O'Neill WW Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the primary angioplasty in myocardial infarction (PAMI) trial. J Am Coll Cardiol. 29:1997;901-907.
102. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. New Engl J Med 1997; 336:1621-1628.
103. Every NR, Parsons LS, Hlaty M, Martin JS, Weaver D A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. New Engl J Med. 335:1996;1253-1260.
104. Ellis SG, da Silva ER, Heydricks Get al. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation. 20:1994;2280-2284.
105. McKendall GR, Forman S, Sopko G, Braunwald E, Williams DO, the Thrombolysis in Myocardial Infarction Investigators. Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Am J Cardiol 1995;76:1108-1111.
106. A statement for the Advanced Cardiac Life Support Committee of the European Resuscitation Council, 1994. Management of peri-arrest arrhythmias. Resuscitation 1994;28:151-159 (Resuscitation 1996;31:281).
107. A statement for the Advanced Cardiac Life Support Committee of the European Resuscitation Council, 1994. Management of peri-arrest arrhythmias. Resuscitation 1994;28:151-159 (Resuscitation 1996;31:281).
108. A statement by the Advanced Cardiac Life Support Committee of the European Resuscitation Council, 1994. Peri-arrest arrhythmias: the management of arrhythmias associated with cardiac arrest. In: Bossaert L, (Ed.) European Resuscitation Council Guidelines for Resuscitation. Amsterdam: Elsevier 1998:159-67.
109. Cotter G, Metzkor E, Kaluski E, Faigenberg Z, Miller R, Simovitz A, Shaham O, Marghitay D, Koren M, Blatt A, Moshkovitz Y, Zaidenstein R, Golik A Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet. 351:1998;389-393.
110. Timmis AD, Fowler MB, Chamberlain DA Comparison of haemodynamic responses to dopamine and salbutamol in severe cardiogenic shock complicating acute myocardial infarction. Br Med J. 282:1981;7-9.
111. Dracup K, Heany DM, Taylor SE, Guzy PM, Breu C Can family members of high-risk cardiac patients learn cardiopulmonary resuscitation? Arch Int Med. 149:1989;61-64.
112. The 1998 European Resuscitation Council guidelines for adult single rescuer basic life support. A Statement from the Working Group on Basic Life Support, and approved by the Executive Committee of the European Resuscitation Council. Resuscitation 1998;37:67-80.
113. Wenzel V, Idris AH, Banner MJ, Fuerst RS, Tucker KJ The composition of gas given by mouth-to-mouth ventilation during CPR. Chest. 106:1994;1806-1810.
114. Moser DK, Coleman S Cardiopulmonary resuscitation: recommendations for improving cardiopulmonary resuscitation skills retention. Heart Lung. 32:1992;372-380.
115. Berg RA, Kern KB, Hilwig RW, Berg MK, Sanders AB, Otto CW, Ewy GA Assisted ventilation does not improve outcome in a porcine model of single-rescuer bystander cardiopulmonary resuscitation. Circulation. 95:1997;1635-1641.
116. Van Hoeyweghen RJ, Bossaert LL, Mullie A, Calle P, Martens P, Buylaert WA, Delooz H, Belgium Cerebral Resuscitation Study Group. Quality and efficency of bystander CPR. Resuscitation 199;26:47-52.
117. Ornato JP Should bystanders perform mouth-to-mouth ventilation during resuscitation. Chest. 106:1994;1641-1642.
118. Locke CJ, Berg RA, Sanders AB, Davis MF, Milander MM, Kern KB, Ewy GA Bystander cardiopulmonary resuscitation: concerns about mouth-to-mouth contact. Arch Intern Med. 155:1995;938-943.
119. The 1998 European Resuscitation Council guidelines for adult advanced life support. A statement from the Working Group on Advanced Life Support, and approved by the Executive Committee of the European Resuscitation Council. Resuscitation 1998;37:81-90.
120. Jakobsson J, Rehnqvist N, Nyquist O Energy requirement for early defibrillation. Eur Heart J. 10:1989;551-554.
121. Weaver WD, Cobb LA, Copass MK, Hallstrom AP Ventricular defibrillation: a comparative trial using 175 and 320 J shocks. New Engl J Med. 307:1982;1101-1106.
122. Kern K, Ewy GA. Clinical defibrillation: optimal transthoracic and open heart techniques. In: Tacker WA Jr, (Ed.) Defibrillation of the Heart, ICDs, AEDs and Manual. St Louis, MO: Mosby-Yearbook Inc, 1994:133-60.
123. Bardy GH, Gliner BE, Kudenchuk PJ, Poole JE, Dolack GL, Jones GK, Anderson J, Troutman C, Johnson G Truncated biphasic pulses for transthoracic defibrillation. Circulation. 91:1995;1768-1774.
124. Reddy R, Gleva MJ, Glina BE, Dolack GR, Kudenchuk PJ, Poole JE, Bardy GH Biphasic transthoracic defibrillation causes fewer ECG ST-segment changes after shock. Ann Emerg Med. 30:1997;127-134.
125. Weisfeldt ML, Kerber RE, McGoldrick P, Moss AJ, Nichol G, Ornato JP, Palmer DG, Riegel B, Smith SC Public access defibrillation: a statement for healthcare professionals from the American Heart Associaton Task Force on automatic external defibrillation. Circulation. 92:1995;2763.
126. A Statement by the Airway and Ventilation Management Working Group of the European Resuscitation Council. Guidelines for the advanced management of the airway and ventilation during resuscitation. Resuscitation 1996;31:201-230.
127. Hapnes SA, Robertson C CPR - drug delivery routes and systems. Resuscitation. 24:1992;137-142.
128. Aitkenhead AR Drug administration during CPR: what route? Resuscitation. 22:1991;191-195.
129. Callaham M, Madsen CD, Barton CW, Saunders CE, Pointer J A randomized clinical trial of high-dose epinephrine and norepinephrine vs. standard-dose epinephrine in pre-hospital cardiac arrest. J Am Med Assoc. 268:1992;2667-2672.
130. Lindner KH, Prengel AW, Pfenninger EG, Lindner IM, Strohmenger H-U, Georgieff M, Lurie KG Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation. 91:1995;215-221.
131. Lindner KH, Dirks B, Strohmenger H-U, Prengel AW, Lindner IM, Lurie KG Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet. 349:1997;535-537.
132. Koster R, Carli P Acid-base management. A statement for the Advanced Life Support Working Party of the European Resuscitation Council. Resuscitation. 24:1992;143-146.
133. Tzivoni D, Banai S, Schuger C, Benhorn J, Keren A, Gottlieb S, Stern S Treatment of torsade de pointes with magnesium sulfate. Circulation. 77:1988;392-397.
134. Wiesfeld ACP, Crijns JGM, Tuininga YS, Lie KI Beta adrenergic blockade in the treatment of sustained ventricular tachycardia or ventricular fibrillation. Pace. 19:1996;1026-1035.
135. Kochanek PM, Hallenbeck JM Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 23:1992;1367-1379.
136. Siesjö BK Historical overview: calcium, ischemia and death of brain cells. Ann NY Acad Sci. 522:1988;638-661.
137. Gustafson I, Edgren E, Hulting J Brain-oriented intensive care after resuscitation from cardiac arrest. Resuscitation. 24:1992;245-261.
138. Kern KB, Sanders AB, Raife J, Milander MM, Otto CW, Ewy GA A study of chest compression rates during cardiopulmonary resuscitation in humans. Arch Intern Med. 152:1992;145-149.
139. Trillo G, von Planta M, Kette F ETCO2 monitoring during low flow states: clinical aims and limits. Resuscitation. 27:1994;1-8.
140. Beauchamp TL, Chindress JF. Principles of Biomedical Ethics. Oxford: Oxford University Press, 1989.
141. Gillon R. Philosophical Medical Ethics. Chichester: Wiley and Sons, 1985.
142. Tomlinson T, Brody H Ethics and communication in do-not-resuscitate orders. New Engl J Med. 318:1988;43-46.
143. Florin D Do not resuscitate orders: the need for the policy. J Royal Coll Phys. 27:1993;1358.
144. Hartford M, Karlson BW, Sjolin M, Holmberg S, Herlitz J Symptoms, thoughts and environmental factors in suspected acute myocardial infarction. Heart Lung. 22:1993;64-70.
145. Dellipiani AW, Cay EL, Phillip AE, Vetter NJ, Colling WA, Donaldson RJ, McCormack P Anxiety after a heart attack. Br Heart J. 38:1976;752-757.
146. Vetter NJ, Cay EL, Phillip AE, Strange RC Anxiety on admission to a coronary care unit. J Psychosomatic Res. 21:1977;73-78.
147. Thompson DR, Cordle CJ, Sutton TW Anxiety in coronary patients. Int Rehab Med. 4:1982;161-164.
148. Harrison TR, Reeves TJ. Ischemic Heart Disease. Chicago Year Book, 1968:295.